High dose epirubicin chemotherapy in untreated poorer prognosis small cell lung cancer.
暂无分享，去创建一个
[1] R. Wolstenholme,et al. Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer. , 1989, Thorax.
[2] P. Fayers,et al. Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party. , 1989, Respiratory medicine.
[3] V. Bramwell,et al. Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients , 1987, International journal of cancer.
[4] A. Gregor,et al. The impact of chemotherapy on small cell carcinoma of the bronchus. , 1986, The Quarterly journal of medicine.
[5] R. J. Cersosimo,et al. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Souhami,et al. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. , 1985, Cancer research.
[7] F. Ganzina. 4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. , 1983, Cancer treatment reviews.
[8] Carter Sk. Chemotherapy of lung cancer. , 1982 .